Veterinary/Animal Vaccines Market Product [Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture], Diseases [Rabies, FMD, Swine Influenza, Strangles, Furunculosis], Technology [DNA, Recombinant, Inactivated, Conjugate] - Forecast to 2021

Table of Contents

1 INTRODUCTION 18

1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 21
1.5 LIMITATIONS 21
1.6 STAKEHOLDERS 22

2 RESEARCH METHODOLOGY 23

2.1 MARKET SIZE ESTIMATION 24
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.2.1 KEY DATA FROM SECONDARY SOURCES 27
2.2.2 KEY DATA FROM PRIMARY SOURCES 28
2.2.2.1 Key industry insights 29
2.3 ASSUMPTIONS 29

3 EXECUTIVE SUMMARY 30

3.1 INTRODUCTION 30
3.2 CURRENT SCENARIO 30
3.3 FUTURE OUTLOOK 31
3.4 CONCLUSION 33

4 PREMIUM INSIGHTS 34

4.1 VETERINARY VACCINES MARKET (2016-2021) TO GROW AT A STEADY RATE 34
4.2 VETERINARY VACCINES MARKET, BY PRODUCT 34
4.3 VETERINARY VACCINES MARKET, BY REGION 35
4.4 LIFECYCLE ANALYSIS, BY REGION 35

5 MARKET OVERVIEW 37

5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 39
5.2.1.1 Increase in livestock population and repeated breakouts of livestock diseases 39
5.2.1.2 Rise in incidences of zoonotic diseases 39
5.2.1.3 Initiatives by various government agencies, animal associations, and leading players 40
5.2.1.4 Introduction of new types of vaccines 40
5.2.2 RESTRAINTS 41
5.2.2.1 Rising costs for the storage of vaccines 41
5.2.2.2 Increasing prices of meat promoting the adoption of vegetarian diets 41
5.2.3 OPPORTUNITIES 42
5.2.3.1 Technological innovation 42
5.2.3.2 Growing awareness of animal health in emerging economies 42
5.2.4 CHALLENGE 43
5.2.4.1 Inadequate surveillance and reporting systems 43

6 VETERINARY VACCINES MARKET, BY PRODUCT 44

6.1 INTRODUCTION 45
6.1.1 PORCINE VACCINES 46
6.1.2 POULTRY VACCINES 46
6.1.3 LIVESTOCK VACCINES 46
6.1.4 COMPANION ANIMAL VACCINES 46
6.1.5 EQUINE VACCINES 46
6.1.6 AQUACULTURE VACCINES 46
6.1.7 OTHER ANIMAL VACCINES 46

7 VETERINARY VACCINES MARKET, BY DISEASE 47

7.1 INTRODUCTION 48
7.2 PORCINE VACCINES 48
7.3 POULTRY VACCINES 49
7.4 LIVESTOCK VACCINES 51
7.4.1 BOVINE VACCINES 51
7.4.2 SMALL RUMINANT VACCINES 52
7.5 COMPANION ANIMAL VACCINES 53
7.5.1 CANINE VACCINES 54
7.5.2 FELINE VACCINES 55
7.6 EQUINE VACCINES 56
7.7 AQUACULTURE VACCINES 57

8 VETERINARY VACCINES MARKET, BY TECHNOLOGY 58

8.1 INTRODUCTION 59
8.2 LIVE ATTENUATED VACCINES 60
8.3 INACTIVATED VACCINES 61
8.4 TOXOID VACCINES 62
8.5 RECOMBINANT VACCINES 63
8.6 CONJUGATE VACCINES 64
8.7 SUBUNIT VACCINES 65
8.8 DNA VACCINES 67

9 VETERINARY VACCINES MARKET, BY REGION 69

9.1 INTRODUCTION 70
9.2 EUROPE 72
9.3 NORTH AMERICA 84
9.4 ASIA 94
9.4.1 CHINA 95
9.4.2 THAILAND 104
9.4.2.1 Regulatory landscape for veterinary vaccines in Thailand 104
9.4.3 INDIA 112
9.4.4 SOUTH KOREA 121
9.4.4.1 Regulatory scenario 122
9.4.4.1.1 Regulatory authorities: veterinary health and safety 122
9.4.4.2 Related regulations 123
9.4.4.3 Regulatory requirements 123
9.4.4.4 Quality and safety control system 124
9.5 REST OF THE WORLD (ROW) 133
9.5.1 BRAZIL 133

10 COMPETITIVE LANDSCAPE 142

10.1 INTRODUCTION 142
10.2 STRATEGIC ANALYSIS 142
10.3 MARKET SHARE ANALYSIS 143
10.4 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS, BY PRODUCT (2013–2015) 144
10.4.1 RECENT NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS BY MARKET PLAYER (2013–2016) 145
10.4.1.1 Zoetis (PFIZER) 145
10.4.1.2 Merck animal health 145
10.4.1.3 Boehringer Ingelheim Inc. 146
10.4.1.4 Ceva animal health 146
10.5 COMPETITIVE SITUATION AND TRENDS 147
10.5.1 NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS 148
10.5.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 149
10.5.3 ACQUISITIONS 150
10.5.4 EXPANSIONS 151
10.5.5 OTHER DEVELOPMENTS 151

11 COMPANY PROFILES 152

11.1 INTRODUCTION 152
(Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis, MnM View)*
11.2 ZOETIS 153
1.3 MERCK ANIMAL HEALTH 156
11.4 MERIAL INC. (SANOFI) 159
11.5 BOEHRINGER INGELHEIM 162
11.6 ELANCO ANIMAL HEALTH (ELI LILLY) 165
11.7 BAYER HEALTHCARE 168
11.8 CEVA ANIMAL HEALTH 170
11.9 HESKA CORPORATION 172
11.10 VETOQUINOL 174
11.11 VIRBAC LTD. 176
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 178

LIST OF TABLES

TABLE 1 REPORTED ZOONOSES (2012-1016) 39
TABLE 2 GROWING INCIDENCE OF ZOONOTIC DISEASES TO DRIVE THE VETERINARY VACCINES MARKET 41
TABLE 3 HIGH STORAGE COST OF VACCINES TO RESTRAIN MARKET GROWTH 42
TABLE 4 TECHNOLOGICAL ADVANCEMENTS, A KEY AREA OF OPPORTUNITY IN THE MARKET 43
TABLE 5 INADEQUATE SURVEILLANCE AND REPORTING SYSTEMS IS A MAJOR CHALLENGE IN THE MARKET 43
TABLE 6 VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 45
TABLE 7 PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 49
TABLE 8 POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 50
TABLE 9 LIVESTOCK VACCINES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 51
TABLE 10 BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 52
TABLE 11 SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 53
TABLE 12 COMPANION ANIMAL VACCINES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 53
TABLE 13 CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 54
TABLE 14 FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 55
TABLE 15 EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 56
TABLE 16 AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 57
TABLE 17 VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 59
TABLE 18 LIVE ATTENUATED VACCINES MARKET SIZE, BY ANIMAL TYPE,
2014–2021 (USD MILLION) 61
TABLE 19 INACTIVATED VACCINES MARKET SIZE, BY ANIMAL TYPE,
2014–2021 (USD MILLION) 62
TABLE 20 TOXOID VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION) 63
TABLE 21 RECOMBINANT VACCINES MARKET SIZE, BY ANIMAL TYPE,
2014–2021 (USD MILLION) 64
TABLE 22 CONJUGATE VACCINES MARKET SIZE, BY ANIMAL TYPE,
2014–2021 (USD MILLION) 65
TABLE 23 SUBUNIT VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION) 66
TABLE 24 DNA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION) 67
TABLE 25 VETERINARY VACCINES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 72
TABLE 26 EUROPE: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 74
TABLE 27 EUROPE: PORCINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 75
TABLE 28 EUROPE: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 76
TABLE 29 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,
2014–2021 (USD MILLION) 76
TABLE 30 EUROPE: BOVINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 77
TABLE 31 EUROPE: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 77
TABLE 32 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 78
TABLE 33 EUROPE: POULTRY VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 78
TABLE 34 EUROPE: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 79
TABLE 35 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2014–2021 (USD MILLION) 79
TABLE 36 EUROPE: CANINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 79
TABLE 37 EUROPE: FELINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 80
TABLE 38 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 81
TABLE 39 EUROPE: EQUINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 81
TABLE 40 EUROPE: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 82
TABLE 41 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 82
TABLE 42 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 83
TABLE 43 NORTH AMERICA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 85
TABLE 44 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,
2014–2021 (USD MILLION) 85
TABLE 45 NORTH AMERICA: BOVINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 86
TABLE 46 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 86
TABLE 47 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 87
TABLE 48 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 88
TABLE 49 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 88
TABLE 50 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 89
TABLE 51 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 89
TABLE 52 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION) 90
TABLE 53 NORTH AMERICA: CANINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 90
TABLE 54 NORTH AMERICA: FELINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 90
TABLE 55 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 91
TABLE 56 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 91
TABLE 57 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 92
TABLE 58 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 92
TABLE 59 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 93
TABLE 60 CHINA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 96
TABLE 61 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,
2014–2021 (USD MILLION) 96
TABLE 62 CHINA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 97
TABLE 63 CHINA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 97
TABLE 64 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 98
TABLE 65 CHINA: POULTRY VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 98
TABLE 66 CHINA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 99
TABLE 67 CHINA: PORCINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 99
TABLE 68 CHINA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 100
TABLE 69 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2014–2021 (USD MILLION) 101
TABLE 70 CHINA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 101
TABLE 71 CHINA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 101
TABLE 72 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 102
TABLE 73 CHINA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 102
TABLE 74 CHINA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 103
TABLE 75 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 103
TABLE 76 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 104
TABLE 77 THAILAND: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 106
TABLE 78 THAILAND: PORCINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 107
TABLE 79 THAILAND: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 107
TABLE 80 THAILAND: POULTRY VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 108
TABLE 81 THAILAND: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 109
TABLE 82 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2014–2021 (USD MILLION) 109
TABLE 83 THAILAND: CANINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 109
TABLE 84 THAILAND: FELINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 110
TABLE 85 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 110
TABLE 86 THAILAND: LIVESTOCK ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2014–2021 (USD MILLION) 111
TABLE 87 THAILAND: BOVINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 111
TABLE 88 THAILAND: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 111
TABLE 89 THAILAND: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 112
TABLE 90 INDIA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 113
TABLE 91 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,
2014–2021 (USD MILLION) 113
TABLE 92 INDIA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 114
TABLE 93 INDIA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 114
TABLE 94 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 115
TABLE 95 INDIA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 116
TABLE 96 INDIA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 116
TABLE 97 INDIA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 117
TABLE 98 INDIA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 117
TABLE 99 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2014–2021 (USD MILLION) 117
TABLE 100 INDIA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 118
TABLE 101 INDIA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 118
TABLE 102 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 119
TABLE 103 INDIA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 119
TABLE 104 INDIA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 120
TABLE 105 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 120
TABLE 106 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 121
TABLE 107 SOUTH KOREA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 125
TABLE 108 SOUTH KOREA: PORCINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 125
TABLE 109 SOUTH KOREA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 126
TABLE 110 SOUTH KOREA: BOVINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 126
TABLE 111 SOUTH KOREA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 127
TABLE 112 SOUTH KOREA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 127
TABLE 113 SOUTH KOREA: POULTRY VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 128
TABLE 114 SOUTH KOREA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 129
TABLE 115 SOUTH KOREA: CANINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 129
TABLE 116 SOUTH KOREA: FELINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 130
TABLE 117 SOUTH KOREA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 130
TABLE 118 SOUTH KOREA: EQUINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 131
TABLE 119 SOUTH KOREA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 131
TABLE 120 SOUTH KOREA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 132
TABLE 121 SOUTH KOREA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 132
TABLE 122 BRAZIL: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 134
TABLE 123 BRAZIL: POULTRY VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 134
TABLE 124 BRAZIL: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 135
TABLE 125 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,
2014–2021 (USD MILLION) 135
TABLE 126 BRAZIL: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 136
TABLE 127 BRAZIL: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 136
TABLE 128 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 137
TABLE 129 BRAZIL: PORCINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 137
TABLE 130 BRAZIL: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 138
TABLE 131 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,
2014–2021 (USD MILLION) 138
TABLE 132 BRAZIL: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 138
TABLE 133 BRAZIL: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 139
TABLE 134 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 139
TABLE 135 BRAZIL: EQUINE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 140
TABLE 136 BRAZIL: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 140
TABLE 137 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,
2014–2021 (USD MILLION) 140
TABLE 138 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 141
TABLE 139 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS (2013–2016) 147
TABLE 140 NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS, 2013–2016 148
TABLE 141 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016 149
TABLE 142 ACQUISITIONS, 2013–2016 150
TABLE 143 EXPANSIONS, 2013–2016 151
TABLE 144 OTHER DEVELOPMENTS, 2013–2016 151

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN: VETERINARY VACCINES MARKET 23
FIGURE 2 MARKET SIZE ESTIMATION APPROACH 25
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 25
FIGURE 4 DATA TRIANGULATION METHODOLOGY 26
FIGURE 5 VETERINARY VACCINES MARKET, BY PRODUCT, 2016 VS. 2021 (USD MILLION) 31
FIGURE 6 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION) 31
FIGURE 7 PORCINE VACCINES MARKET, BY DISEASE, 2016 VS. 2021 (USD MILLION) 32
FIGURE 8 CANINE VACCINES MARKET, BY DISEASE, 2016 VS. 2021 (USD MILLION) 32
FIGURE 9 VETERINARY VACCINES MARKET, BY REGION, 2016 (USD MILLION) 33
FIGURE 10 ATTRACTIVE MARKET OPPORTUNITIES 34
FIGURE 11 PORCINE VACCINES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2016 34
FIGURE 12 ASIA EXPECTED TO BE THE FASTEST-GROWING REGION DURING THE FORECAST PERIOD 35
FIGURE 13 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 35
FIGURE 14 INCREASE IN LIVESTOCK POPULATION AND REPEATED BREAKOUTS OF LIVESTOCK DISEASES TO BOOST MARKET GROWTH 38
FIGURE 15 PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL VETERINARY VACCINES MARKET IN 2016 45
FIGURE 16 PORCINE CIRCOVIRUS SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN PORCINE VACCINES MARKET, BY 2021 48
FIGURE 17 INFECTIOUS BRONCHITIS SEGMENT TO DOMINATE THE POULTRY VACCINES MARKET IN 2016 50
FIGURE 18 BVD SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE BOVINE VACCINES MARKET BY 2021 51
FIGURE 19 CLOSTRIDIAL DISEASES SEGMENT TO DOMINATE THE SMALL RUMINANT VACCINES MARKET IN 2016 52
FIGURE 20 CANINE DISTEMPER SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE CANINE VACCINES MARKET BY 2021 54
FIGURE 21 FELINE RABIES SEGMENT IS EXPECTED TO DOMINATE THE FELINE VACCINES MARKET IN 2016 55
FIGURE 22 EQUINE RHINOPNEUMONITIS SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE EQUINE VACCINES MARKET 56
FIGURE 23 VIBRIOSIS TO DOMINATE THE AQUACULTURE VACCINES MARKET, BY DISEASE,
IN 2016 57
FIGURE 24 LIVE ATTENUATED VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2016 59
FIGURE 25 POULTRY VACCINES SEGMENT IS EXPECTED TO DOMINATE THE LIVE ATTENUATED VACCINES MARKET IN 2016 60
FIGURE 26 COMPANION ANIMAL VACCINES SEGMENT TO REGISTER HIGHEST GROWTH RATE IN THE INACTIVATED VACCINES MARKET 62
FIGURE 27 LIVESTOCK VACCINES TO DOMINATE THE TOXOID VACCINES MARKET IN 2016 63
FIGURE 28 POULTRY VACCINES SEGMENT TO GROW AT THE HIGHEST RATE IN THE RECOMBINANT VACCINES MARKET 64
FIGURE 29 PORCINE VACCINES TO DOMINATE THE CONJUGATE VACCINES MARKET IN 2016 65
FIGURE 30 LIVESTOCK VACCINES TO GROW AT THE HIGHEST RATE IN THE SUBUNIT VACCINES MARKET FROM 2016 TO 2021 66
FIGURE 31 PORCINE VACCINES SEGMENT IS EXPECTED TO DOMINATE THE DNA VACCINES MARKET 67
FIGURE 32 GEOGRAPHIC SNAPSHOT: ASIA TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 70
FIGURE 33 ASIA, AN ATTRACTIVE REGION FOR ALL PRODUCT CATEGORIES 71
FIGURE 34 EUROPE WILL CONTINUE TO LEAD THE GLOBAL VETERINARY VACCINES MARKET IN THE FORECAST PERIOD 71
FIGURE 35 THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY THE GROWING PRODUCTION OF PIG MEAT IN THE FORECAST PERIOD 73
FIGURE 36 THE PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN VETERINARY VACCINES MARKET IN 2016 74
FIGURE 37 RECOMBINANT VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT IN THE EUROPEAN VETERINARY VACCINES MARKET DURING THE FORECAST PERIOD 75
FIGURE 38 THE INACTIVATED VACCINES TECHNOLOGY SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN COMPANION ANIMAL VACCINES MARKET 80
FIGURE 39 COMPANION ANIMAL VACCINES WILL BE THE FASTEST-GROWING SEGMENT FOR NORTH AMERICAN VETERINARY VACCINES MARKET IN THE FORECAST PERIOD 84
FIGURE 40 THE LIVE ATTENUATED VACCINES TECHNOLOGY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN LIVESTOCK VACCINES MARKET 87
FIGURE 41 ASIA MARKET SNAPSHOT: THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY INCREASING INCIDENCES OF ZOONOTIC DISEASES 94
FIGURE 42 THE LIVESTOCK VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN CHINA 95
FIGURE 43 CONJUGATE VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT IN THE ASIAN VETERINARY VACCINES MARKET DURING THE FORECAST PERIOD 100
FIGURE 44 STEPS INVOLVED IN THE MARKETING AUTHORIZATION APPROVAL OF VETERINARY VACCINES IN THAILAND 105
FIGURE 45 REGISTRATION PROCESS 105
FIGURE 46 THE PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE THAILAND VETERINARY VACCINES MARKET IN 2016 106
FIGURE 47 RECOMBINANT VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE VETERINARY VACCINES MARKET IN THAILAND DURING THE FORECAST PERIOD 108
FIGURE 48 LIVESTOCK VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN INDIA 113
FIGURE 49 CONJUGATE VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE INDIAN LIVESTOCK VACCINES MARKET 115
FIGURE 50 SOUTH KOREAN VETERINARY VACCINES MARKET: REGULATORY AUTHORITIES AND THEIR RESPECTIVE ROLES 122
FIGURE 51 PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN SOUTH KOREA 124
FIGURE 52 INACTIVATED VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE SOUTH KOREAN POULTRY VACCINES MARKET 128
FIGURE 53 POULTRY VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN BRAZIL 133
FIGURE 54 INACTIVATED VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE POULTRY VACCINES MARKET IN BRAZIL 135
FIGURE 55 KEY DEVELOPMENTS IN THE VETERINARY VACCINES MARKET, 2013-2016 142
FIGURE 56 GLOBAL VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2015 143
FIGURE 57 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS (2013–2016) 144
FIGURE 58 ZOETIS (PFIZER) FOCUSED ON PORCINE AND POULTRY SEGMENT IN THE LAST FEW YEARS (2013-2016) 145
FIGURE 59 MERCK CONCENTRATED ON THE AQUACULTURE SEGMENT (2013-2016) 145
FIGURE 60 BOEHRINGER INGELHEIM MAINLY CONCENTRATED ON EQUINE AND PORCINE SEGMENT (2013-2016) 146
FIGURE 61 CEVA RELEASED NEW PRODUCTS FOR THE POULTRY SEGMENT (2013–2016) 146
FIGURE 62 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS—THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS BETWEEN 2013 & 2016 148
FIGURE 63 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS 152
FIGURE 64 ZOETIS: COMPANY SNAPSHOT 153
FIGURE 65 MERCK ANIMAL HEALTH: COMPANY SNAPSHOT 156
FIGURE 66 MERIAL INC. (SANOFI): COMPANY SNAPSHOT 159
FIGURE 67 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT 162
FIGURE 68 ELI LILLY: COMPANY SNAPSHOT 165
FIGURE 69 BAYER HEALTHCARE: COMPANY SNAPSHOT 168
FIGURE 70 CEVA ANIMAL HEALTH: COMPANY SNAPSHOT 170
FIGURE 71 HESKA CORPORATION: COMPANY SNAPSHOT 172
FIGURE 72 VETOQUINOL: COMPANY SNAPSHOT 174
FIGURE 73 VIRBAC LTD.: COMPANY SNAPSHOT 176

当レポートのプレスリリースは発行されておりません。